Mangoceuticals (MGRX) Non-Current Assets (2022 - 2026)

Mangoceuticals has disclosed Non-Current Assets across 5 years of filings, most recently posting $14.2 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $14.2 million, down 34.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.2 million (down 34.02% YoY), and the FY2025 annual result was $14.5 million, down 4.92% from the prior year.
• Non-Current Assets came in at $14.2 million for Q1 2026 at Mangoceuticals, down from $14.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $21.6 million in Q1 2025 to a low of $211639.0 in Q1 2024.
• The 5-year median for Non-Current Assets is $14.4 million (2025), against an average of $9.5 million.
• Across the five-year window, Non-Current Assets surged 10095.29% in 2025 and tumbled 34.02% in 2026, its largest moves.
• Mangoceuticals' Non-Current Assets stood at $308682.0 in 2022, then slumped by 30.22% to $215391.0 in 2023, then jumped by 7001.0% to $15.3 million in 2024, then slipped by 4.92% to $14.5 million in 2025, then fell by 2.1% to $14.2 million in 2026.
• The last three Non-Current Assets figures came in at $14.2 million (Q1 2026), $14.5 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.